Literature DB >> 24687993

Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation.

Anuradha Balasubramanian1, Genri Kawahara1, Vandana A Gupta1, Anete Rozkalne1, Ariane Beauvais2, Louis M Kunkel3, Emanuela Gussoni4.   

Abstract

Previously, we identified family with sequence similarity 65, member B (Fam65b), as a protein transiently up-regulated during differentiation and fusion of human myogenic cells. Silencing of Fam65b expression results in severe reduction of myogenin expression and consequent lack of myoblast fusion. The molecular function of Fam65b and whether misregulation of its expression could be causative of muscle diseases are unknown. Protein pulldowns were used to identify Fam65b-interacting proteins in differentiating human muscle cells and regenerating muscle tissue. In vitro, human muscle cells were treated with histone-deacetylase (HDAC) inhibitors, and expression of Fam65b and interacting proteins was studied. Nontreated cells were used as controls. In vivo, expression of Fam65b was down-regulated in developing zebrafish to determine the effects on muscle development. Fam65b binds to HDAC6 and dysferlin, the protein mutated in limb girdle muscular dystrophy 2B. The tricomplex Fam65b-HDAC6-dysferlin is transient, and Fam65b expression is necessary for the complex to form. Treatment of myogenic cells with pan-HDAC or HDAC6-specific inhibitors alters Fam65b expression, while dysferlin expression does not change. Inhibition of Fam65b expression in developing zebrafish results in abnormal muscle, with low birefringence, tears at the myosepta, and increased embryo lethality. Fam65b is an essential component of the HDAC6-dysferlin complex. Down-regulation of Fam65b in developing muscle causes changes consistent with muscle disease.-Balasubramanian, A., Kawahara, G., Gupta, V. A., Rozkalne, A., Beauvais, A., Kunkel, L. M., Gussoni, E. Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation. © FASEB.

Entities:  

Keywords:  acetylation; muscular dystrophy; myoblast; zebrafish

Mesh:

Substances:

Year:  2014        PMID: 24687993      PMCID: PMC4062822          DOI: 10.1096/fj.13-246470

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  66 in total

1.  Isolation and characterization of human fetal myoblasts.

Authors:  Ariya D Lapan; Emanuela Gussoni
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Building muscle: molecular regulation of myogenesis.

Authors:  C Florian Bentzinger; Yu Xin Wang; Michael A Rudnicki
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

Review 3.  Myoblast fusion: lessons from flies and mice.

Authors:  Susan M Abmayr; Grace K Pavlath
Journal:  Development       Date:  2012-02       Impact factor: 6.868

4.  HDAC6 is required for invadopodia activity and invasion by breast tumor cells.

Authors:  Mercedes Rey; Marie Irondelle; François Waharte; Floria Lizarraga; Philippe Chavrier
Journal:  Eur J Cell Biol       Date:  2010-10-23       Impact factor: 4.492

5.  Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor.

Authors:  Fedik Rahimov; Oliver D King; Leigh C Warsing; Rachel E Powell; Charles P Emerson; Louis M Kunkel; Kathryn R Wagner
Journal:  Physiol Genomics       Date:  2011-01-25       Impact factor: 3.107

6.  Post-translational control of Myc function during differentiation.

Authors:  Maralice Conacci-Sorrell; Robert N Eisenman
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

7.  Human fetal skeletal muscle contains a myogenic side population that expresses the melanoma cell-adhesion molecule.

Authors:  Ariya D Lapan; Anete Rozkalne; Emanuela Gussoni
Journal:  Hum Mol Genet       Date:  2012-05-24       Impact factor: 6.150

8.  Characterization of zebrafish dysferlin by morpholino knockdown.

Authors:  Genri Kawahara; Peter R Serafini; Jennifer A Myers; Matthew S Alexander; Louis M Kunkel
Journal:  Biochem Biophys Res Commun       Date:  2011-08-27       Impact factor: 3.575

Review 9.  Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases.

Authors:  Silvia Consalvi; Valentina Saccone; Lorenzo Giordani; Giulia Minetti; Chiara Mozzetta; Pier Lorenzo Puri
Journal:  Mol Med       Date:  2011-02-07       Impact factor: 6.354

10.  Dysferlin interacts with histone deacetylase 6 and increases alpha-tubulin acetylation.

Authors:  Sabrina Di Fulvio; Bilal A Azakir; Christian Therrien; Michael Sinnreich
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

View more
  12 in total

1.  Enzymatic cleavage of myoferlin releases a dual C2-domain module linked to ERK signalling.

Authors:  Ann-Katrin Piper; Samuel E Ross; Gregory M Redpath; Frances A Lemckert; Natalie Woolger; Adam Bournazos; Peter A Greer; Roger B Sutton; Sandra T Cooper
Journal:  Cell Signal       Date:  2017-02-10       Impact factor: 4.315

Review 2.  Engineered skeletal muscles for disease modeling and drug discovery.

Authors:  Jason Wang; Alastair Khodabukus; Lingjun Rao; Keith Vandusen; Nadia Abutaleb; Nenad Bursac
Journal:  Biomaterials       Date:  2019-08-08       Impact factor: 12.479

3.  Ripor2 is involved in auditory hair cell stereociliary bundle structure and orientation.

Authors:  Oscar Diaz-Horta; Clemer Abad; Filiz Basak Cengiz; Guney Bademci; Pat Blackwelder; Katherina Walz; Mustafa Tekin
Journal:  J Mol Med (Berl)       Date:  2018-10-03       Impact factor: 4.599

4.  The circular RNA ACR attenuates myocardial ischemia/reperfusion injury by suppressing autophagy via modulation of the Pink1/ FAM65B pathway.

Authors:  Lu-Yu Zhou; Mei Zhai; Yan Huang; Sheng Xu; Tao An; Yun-Hong Wang; Rong-Cheng Zhang; Cui-Yun Liu; Yan-Han Dong; Man Wang; Li-Li Qian; Murugavel Ponnusamy; Yu-Hui Zhang; Jian Zhang; Kun Wang
Journal:  Cell Death Differ       Date:  2018-10-22       Impact factor: 15.828

5.  FAM65B controls the proliferation of transformed and primary T cells.

Authors:  Jeanne Froehlich; Margaux Versapuech; Laura Megrelis; Quitterie Largeteau; Sylvain Meunier; Corinne Tanchot; Georges Bismuth; Jérôme Delon; Marianne Mangeney
Journal:  Oncotarget       Date:  2016-09-27

6.  A potential regulatory network underlying distinct fate commitment of myogenic and adipogenic cells in skeletal muscle.

Authors:  Wenjuan Sun; Ting He; Chunfu Qin; Kai Qiu; Xin Zhang; Yanhong Luo; Defa Li; Jingdong Yin
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

7.  Exon 32 Skipping of Dysferlin Rescues Membrane Repair in Patients' Cells.

Authors:  Florian Barthélémy; Cédric Blouin; Nicolas Wein; Vincent Mouly; Sébastien Courrier; Eugénie Dionnet; Virginie Kergourlay; Yves Mathieu; Luis Garcia; Gillian Butler-Browne; Christophe Lamaze; Nicolas Lévy; Martin Krahn; Marc Bartoli
Journal:  J Neuromuscul Dis       Date:  2015-09-02

8.  2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy.

Authors:  Zaid H Maayah; Jody Levasseur; Ramanaguru Siva Piragasam; Ghada Abdelhamid; Jason R B Dyck; Richard P Fahlman; Arno G Siraki; Ayman O S El-Kadi
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

9.  Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity.

Authors:  Zelalem Petros; Ming-Ta Michael Lee; Atsushi Takahashi; Yanfei Zhang; Getnet Yimer; Abiy Habtewold; Wondwossen Amogne; Getachew Aderaye; Ina Schuppe-Koistinen; Taisei Mushiroda; Eyasu Makonnen; Michiaki Kubo; Eleni Aklillu
Journal:  BMC Genomics       Date:  2016-09-26       Impact factor: 3.969

10.  Emerging Functional Differences between the Synaptotagmin and Ferlin Calcium Sensor Families.

Authors:  Colin P Johnson
Journal:  Biochemistry       Date:  2017-11-29       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.